Spyre Therapeutics Inc. (SYRE)

SYRE trades at $16.24, 8.3% above the near-term max pain of $15 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($12.5-$60), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for SYRE shows a downward trend from 60 to 12.5, indicating bearish sentiment or hedging activity. The 211% spread signals divergent expectations across timeframes. Levels distributed around 16.24. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.